Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/113189
Title: Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet
Authors: Razquin, Cristina
Ruiz-Canela, Miguel
Toledo, Estefania
Hernández-Alonso, Pablo
Clish, Clary B.
Guasch-Ferré, Marta
Li, Jun
Wittenbecher, Clemens
Dennis, Courtney
Alonso-Gómez, Angel
Fitó, Montse
Liang, Liming
Corella, Dolores
Gómez-Gracia, Enrique
Estruch, Ramon
Fiol, Miquel
Lapetra, Jose
Serra Majem, Luis 
Ros, Emilio
Aros, Fernando
Salas-Salvadó, Jordi
Hu, Frank B.
Martínez-González, Miguel A.
UNESCO Clasification: 32 Ciencias médicas
3206 Ciencias de la nutrición
Keywords: Atrial Fibrillation
Case–Control
Heart Failure
Kynurenine
Mediterranean Diet, et al
Issue Date: 2021
Journal: The American journal of clinical nutrition 
Abstract: BACKGROUND: The tryptophan-kynurenine pathway is linked to inflammation. We hypothesize that metabolites implicated in this pathway may be associated with the risk of heart failure (HF) or atrial fibrillation (AF) in a population at high risk of cardiovascular disease. OBJECTIVES: We aimed to prospectively analyze the associations of kynurenine-related metabolites with the risk of HF and AF and to analyze a potential effect modification by the randomized interventions of the PREDIMED (Prevención con Dieta Mediterránea) trial with Mediterranean diet (MedDiet). METHODS: Two case-control studies nested within the PREDIMED trial were designed. We selected 324 incident HF cases and 502 incident AF cases individually matched with ≤3 controls. Conditional logistic regression models were fitted. Interactions with the intervention were tested for each of the baseline plasma metabolites measured by LC-tandem MS. RESULTS: Higher baseline kynurenine:tryptophan ratio (OR for 1 SD: 1.20; 95% CI: 1.01, 1.43) and higher levels of kynurenic acid (OR: 1.19; 95% CI: 1.01, 1.40) were associated with HF. Quinolinic acid was associated with AF (OR: 1.15; 95% CI: 1.01, 1.32) and HF (OR: 1.25; 95% CI: 1.04, 1.49). The MedDiet intervention modified the positive associations of kynurenine (Pinteraction = 0.006), kynurenic acid (Pinteraction = 0.008), and quinolinic acid (Pinteraction = 0.033) with HF and the association between kynurenic acid and AF (Pinteraction = 0.02). CONCLUSIONS: We found that tryptophan-kynurenine pathway metabolites were prospectively associated with higher HF risk and to a lesser extent with AF risk. Moreover, an effect modification by MedDiet was observed for the association between plasma baseline kynurenine-related metabolites and the risk of HF, showing that the positive association of increased levels of these metabolites and HF was restricted to the control group.
URI: http://hdl.handle.net/10553/113189
DOI: 10.1093/ajcn/nqab238
Source: The American journal of clinical nutrition[EISSN 1938-3207],v. 114 (5), p. 1646-1654, (Noviembre 2021)
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

18
checked on May 5, 2024

Page view(s)

72
checked on May 4, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.